Overall survival (OS) implications for patients with mCRPC through coverage and adoption of nuclear AR-V7 testing by healthcare systems

Category Systematic review
JournalAnnals of Oncology
Year 2018
This article has no abstract
Epistemonikos ID: 8d79326992112235d00009dec8884cd5af3a3517
First added on: Feb 11, 2025